(NASDAQ)
181.35
-8.08   (-4.27%)
After Hours: 181.70 +0.35 (+0.19%)
Volume (24h) Market Cap. Day Range 52w Range
904.97K 8.82B 178.18 - 196.48 0 - 196.48
Jan-14-21 12:27PM Want to Use ETFs to Play Biotech? Choose Wisely.Barrons.com
08:00AM Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2Business Wire
Jan-11-21 05:12AM SKB finalizes new lease agreement with Twist Bioscience Corporation ("Twist") at recently repositioned mixed-use campus, ParkWorks Industrial CenterPR Newswire
Jan-07-21 08:00AM Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA ControlsBusiness Wire
Jan-04-21 08:00AM Twist Bioscience to Present at the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
Dec-31-20 05:00AM The Best Stock Picker of 2020 Wins With Disruptive DNABloomberg
Dec-23-20 08:00AM Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2Business Wire
Dec-22-20 08:00AM Twist Bioscience to Expand Commercial Capabilities with Factory of the FutureBusiness Wire
Dec-21-20 06:42AM How a Relentless Dealmaker Cracked Silicon Valley’s Bros ClubBloomberg
Dec-18-20 10:20AM Is TWST A Good Stock To Buy Now According To Hedge Funds?Insider Monkey
Dec-10-20 08:00AM Twist Bioscience Expands Gene Product Line with Launch of Clonal-Ready Gene FragmentsBusiness Wire
Dec-07-20 04:05AM Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesBusiness Wire
Dec-02-20 08:34AM Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common StockBusiness Wire
Dec-01-20 04:01AM Twist Bioscience Announces Proposed Public Offering of Common StockBusiness Wire
Nov-26-20 02:15AM Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation (NASDAQ:TWST) Price Target To US$110Simply Wall St.
Nov-24-20 08:00AM Twist Bioscience to Present at Upcoming Virtual Investor ConferencesBusiness Wire
Nov-23-20 06:00AM Twist Bioscience Corp (TWST) Q4 2020 Earnings Call TranscriptMotley Fool
07:54AM Twist Bioscience: Q4 Earnings InsightsBenzinga
Nov-23-20 07:01AM Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial ResultsBusiness Wire
07:00AM Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 AntibodiesBusiness Wire
Nov-23-20 06:15AM Twist Bioscience Corp. to Host Earnings CallACCESSWIRE
Nov-20-20 10:04AM Earnings Preview for Twist BioscienceBenzinga
Nov-19-20 08:00AM Twist Bioscience and Biotia Announce Research Use Only Availability of First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay for Characterization and Surveillance of the VirusBusiness Wire
Nov-18-20 08:00AM Twist Bioscience Ranked 60th Fastest Growing Company in North America on Deloitte’s 2020 Fast 500™Business Wire
Nov-16-20 12:30PM Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should KnowZacks
08:00AM Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral PanelBusiness Wire
Nov-16-20 07:59AM Twist Bioscience Continues Support for Next Generation of Synthetic Biologists Through Work with iGEM CompetitionBusiness Wire
Nov-12-20 03:15AM Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNABusiness Wire
Nov-10-20 08:00AM Twist Bioscience to Present at the Stifel 2020 Virtual Healthcare ConferenceBusiness Wire
Nov-02-20 08:00AM Twist Bioscience to Report Fiscal 2020 Fourth Quarter and Full Year Financial Results on Monday, November 23, 2020Business Wire
Oct-29-20 08:00AM Twist Bioscience Showcases Next-Generation Sequencing Presentations at Virtual American Society for Human Genetics 2020 Annual MeetingBusiness Wire
Oct-27-20 08:00AM Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into SpaceBusiness Wire
Oct-20-20 09:56AM Benzinga's Top Upgrades, Downgrades For October 20, 2020Benzinga
Oct-13-20 03:03AM Hedge Funds Can’t Stop Buying Twist Bioscience Corporation (TWST)Insider Monkey
08:00AM Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020Business Wire
Oct-13-20 07:00AM Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell TherapiesBusiness Wire
Sep-18-20 08:00AM Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin AwardBusiness Wire
Sep-16-20 01:38AM Shareholders Are Thrilled That The Twist Bioscience (NASDAQ:TWST) Share Price Increased 107%Simply Wall St.
Sep-03-20 08:00AM Twist Bioscience to Present at Upcoming Virtual Investor ConferencesBusiness Wire
Sep-02-20 08:00AM Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody ProgramBusiness Wire
Aug-20-20 08:00AM Twist Bioscience Synthetic DNA Stores New Netflix Original Series ‘BIOHACKERS’Business Wire
Aug-13-20 10:35AM Twist Bioscience Is Rapidly Growing Its Customer Base. Can It Turn a Profit?Motley Fool
Aug-06-20 07:10AM Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue EstimatesZacks
04:05AM Twist Bioscience Reports Third Quarter Fiscal 2020 Financial ResultsBusiness Wire
Aug-04-20 08:00AM Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of AntibodiesBusiness Wire
Jul-30-20 12:34PM Will Twist Bioscience (TWST) Report Negative Q3 Earnings? What You Should KnowZacks
08:00AM Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020Business Wire
Jul-28-20 08:00AM Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19Business Wire
Jul-23-20 08:00AM Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public PolicyBusiness Wire
Jul-22-20 08:21AM Twist Bioscience Has Gained 186% in 2020. Is the Synbio Stock a Buy?Motley Fool
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.
Cap:    |  Volume (24h):